当地时间12月19日，中国(湖北)第19批援莱索托医疗队在马塞卢地区医院重症监护室开展关于压力 性损伤预防与治疗的专题培训，受到当地医护人员的欢迎。 此次培训是国家项目《中国湖北省武汉市中西医结合医院—莱索托王国马塞卢地区医院"重症医 学"建设项目》线下培训的重要组成部分。此前该医疗队还在此开展呼吸机操作培训，直接将教学现场 设在重症监护室病房，在病房内现场演示了呼吸机的实际操作，就设备使用中的重点环节进行了手把手 指导。 中国援莱索托医疗队始终致力于帮助当地提升医疗服务能力，通过多种形式分享中国医疗经验，为 促进莱索托医疗卫生事业发展持续贡献力量。医疗队队长吴辉表示，未来将继续结合莱索托实际医疗需 求，开展更多针对性培训与技术交流，切实帮助当地培养医疗骨干力量，改善医疗服务质量，为增进中 莱两国人民健康福祉作出积极努力。 本次专题培训由医疗队队员、骨科副主任医师左昌俊主讲。他通过理论讲解与病例展示相结合的方 式，向重症监护室及骨科、内科医护人员系统介绍了压力性损伤防治的基本理论知识与操作技巧，获得 了在场医护人员积极反馈。 压力性损伤是临床常见病症，在重症监护室昏迷患者、严重多发性骨折患者以及中风偏瘫老年患 ...

19日，在协和质子医学中心首批接受治疗的3名患者均为4岁至10岁儿童。10岁的武汉男 孩洋洋（化名）罹患一种罕见的脑瘤——毛细胞黏液型星形细胞瘤，由于肿瘤位于中枢神经 系统深处，毗邻重要脑功能区，常规放疗风险极大。协和质子医学中心团队经过综合评估， 为洋洋制定了"质子刀"计划。洋洋躺在治疗床上，经历10来分钟的精准摆位，真正的放疗时 间仅用了10余秒。他说："没有任何感觉，看得见机器快速旋转，好神奇！"未来他还将经历 每周5次、共计30次的治疗。 协和医院肿瘤中心主任杨坤禹教授介绍，"质子刀"具备独特的"布拉格峰"效应，射线在 到达肿瘤前能量释放极低，抵达病灶则瞬间释放最大能量，随后能量迅速跌落为零，实 现"专灭癌细胞、不伤好细胞"的精准爆破，将副反应降到近乎为零。协和"质子刀"系统搭载 了高精度笔形束扫描技术，能360度无死角瞄准靶区，精度校准至亚毫米级远高于国际标 准，即便肿瘤随呼吸移动，系统也能即时"追踪"和"锁定"。"质子治疗是目前国际推荐的儿 童脑肿瘤及实体瘤的优选方案，也适用于需要放疗的实体瘤成年患者。"杨坤禹说。 编辑：赖俊 质子射线治疗被比作"质子刀"，是当下最前沿的肿瘤放疗技术。12月19日 ...

●蔡伟 "医生，我的胃老是不舒服，吃了东西总不消化。"12月16日，在四师总医院可克达拉市院区消化内科门 诊，一位面色憔悴的患者正向王佳医生描述病情。王佳专注倾听后问道："你平时饮食规律吗？是不是 喜欢吃辛辣刺激的食物？"问诊结束后，她还不忘叮嘱患者："药要按时吃，平时要多注意养护胃。" 与王佳一样，在扎实的临床实践基础上，多批次镇江援疆医疗团队专家积极推动技术创新与科研落地， 在四师总医院成功开展了2项新技术，协助申报了4项科研项目，并发表学术论文1篇。其中，甲状腺射 频消融手术填补了四师可克达拉市在该领域的技术空白。 数据显示，2024年至2025年，镇江援疆医疗组累计开展基层巡诊等活动18场次；"润心明眸"项目为四师 可克达拉市25所团场学校的学生进行先心病与肝包虫病筛查，累计惠及群众近万人次。 谈及援疆的心愿，王佳的话语朴素而深情："一年时间虽不长，我和同事更想'授人以渔'，留下更多适 合这里的技术与经验，让两地协作的情谊长长久久。" 门诊，是王佳援疆工作的第一个"战场"。面对络绎不绝的患者，她始终耐心细致问诊。在诊疗过程中， 她敏锐察觉到本地幽门螺杆菌感染率和肠息肉发病率偏高。通过反复问诊与观察，她 ...

（来源：千龙网） 新华社重庆12月20日电（记者李晓婷）走进重庆市云阳县中医院体重管理中心，淡淡的中药味扑面而 来。诊室外的候诊区，有很多年轻面孔。 "听说这里是靠调理体质来减重，我专门过来试试。"26岁的上班族李娅说。从中药茶饮到养生功法，从 辨明体质到综合调理，越来越多青年人在尝试中医"花式减重"。 "90后"教师刘楠就是其中一员。产后体重滞留、长期久坐工作，让她陷入了"喝水都胖"的焦虑。"医院 没有直接开药打针，而是辨明我的体质后，再对症制定了一个调理的方案。"刘楠说，在穴位进行蛋白 质线埋植，每周一次艾灸与耳穴压丸，日常饮用代茶饮，配合太极拳等适宜的养生功法…… "我们不只是帮患者'掉秤'，更主要是帮他们找回身体的平衡状态。"云阳县中医院体重管理中心负责人 盛杰霞说，中医的目标不是盲目"泻"体重，而是通过综合方法健脾、祛湿、化痰，把偏颇的体质调回平 衡状态，体重下降是水到渠成的结果。 中医调理从根源上"改良土壤"，还需要与其他多学科协作实现"精准灌溉"。 "以前减肥只知道少吃多动，没想到还要考虑代谢、激素这些问题。"身高174厘米、原始体重超101公斤 的乔梁说。 传统单科门诊就像"单兵作战"，而MD ...

让群众在家门口享受优质公共服务 12月18日，市委副书记、市长刘文萍到南和区调研紧密型县域医共体建设、长期护理保险、普惠托育服 务等工作。她强调，要坚持以人民为中心，精准对接"一老一小"和特殊群体健康需求，聚焦群众期盼， 办好民生实事，让群众在家门口享受优质公共服务。市领导钱丽霞参加调研。 刘文萍来到贾宋中心卫生院、怡康养护中心、南和区人民医院，实地察看特色专科、远程会诊、特殊护 理、托育服务等运行情况。她强调，要坚持民生为大，适应"一老一小"人口变化形势，优化医疗、养 护、托育等民生资源配置，让群众享受到更加普惠的民生成果。要把紧密型县域医共体建设作为解决群 众看病难问题的关键抓手，选好建强牵头医院，打造乡镇卫生院特色专科，灵活式、亲情式推动专家下 沉，稳步推进医疗资源上下贯通和人财物一体管理，真正实现大病不出县、小病不出乡。要持续深化长 期护理保险试点改革成效，做好政策衔接，统筹民政、卫健医养资源和保险机构资金保障，探索可持续 筹资缴费机制，让失能人士护得起、有所护。要持续提升托育服务质量，充分利用医院、学校、社会机 构等托育资源，加快构建以托育综合服务中心为枢纽，以托育机构、社区嵌入式托育、用人单位办托 ...

邯郸明仁医院党总支成立于2004年，张子明被选为党总支书记。他始终坚持"以党建为引领，以党建促 院建，以院建融合党建"的办院方针，将党建工作与医院管理、医疗服务、文化建设等各项业务深度融 合，推动医院从一家普通民营医院成长为三级甲等中西医结合医院、河北大学非直属附属医院。 在组织建设上，张子明带头强化党组织凝聚力与战斗力，定期组织开展党组织生活，加强党员思想教育 与业务培训，推动党员在医疗服务、学科建设、公益行动中发挥先锋模范作用。在他的带领下，医院党 总支先后获评"河北省两新组织党建示范点""邯郸市非公基层党组织建设示范点""邯郸市红色社会组 织"示范单位，党建案例荣获"全国卫生健康基层党建创新案例奖"。 在党建与业务融合实践中，张子明探索"党建+"模式，将党建引领贯穿医院发展各环节。以"党建+质量 建设"保障医疗安全，推动医院完善医疗质量安全管理体系，强化院科两级质控，落实核心制度，使医 院在河北省医院品质管理成果大赛中屡获佳绩；以"党建+学科建设"培育优势专科，通过政策倾斜、资 源扶持，推动脑病科、心血管病科、肾病科成为"河北省中医优势专科"，康复科、内分泌科、肺病科、 肿瘤科、妇科成为省级中医优势专科 ...

Investment Rating - The report maintains a positive outlook on the insomnia treatment market, highlighting the potential for new drug sales performance in this sector [20][32]. Core Insights - The insomnia treatment market in China is characterized by a significant unmet need, with over 200 million individuals estimated to suffer from insomnia symptoms, representing a large consumer market potential [16][24]. - The report emphasizes the shift towards innovative insomnia medications, particularly focusing on new types of benzodiazepine receptor agonists (BZRAs) and dual orexin receptor antagonists (DORAs) as key areas for development [25][38]. - The introduction of new drugs like JY-202 (地达西尼) and DORA medications is expected to reshape the market dynamics, with a forecasted rapid increase in market share and sales [34][39]. Market Overview - The insomnia drug market in China has seen stagnant growth due to a lack of new effective treatments, with the market size in 2023 estimated at 31.62 billion yuan [24]. - The report outlines the historical sales performance of major insomnia medications, indicating a long gap since the last new product launch in 2007, which has contributed to the current market stagnation [24][25]. - The report projects a significant increase in the market size and sales for innovative insomnia drugs, particularly with the anticipated approval and market entry of new products [34][39]. Drug Development Trends - The report identifies two main directions for insomnia drug innovation: improvements on existing BZRAs and the development of DORAs, which are expected to have lower addiction risks and better patient compliance [25][38]. - The new drug JY-202 is highlighted for its selective action on the GABAA receptor, which may reduce side effects associated with traditional insomnia medications [34]. - The report also notes the successful clinical trial results for DORAs, which have shown significant improvements in sleep quality without the risk of addiction, making them suitable for broader consumer use [38][39]. Key Players and Recommendations - The report suggests focusing on companies like 京新药业 (JY-202) and 先声药业 (DORA medications) as they are positioned to capitalize on the emerging market opportunities in insomnia treatment [34][39]. - It recommends monitoring the sales performance of these new drugs as they enter the market, particularly in the context of changing consumer behavior and increasing awareness of sleep health [20][32].

12月20日，国家医保局官网发布新一批定点医药机构相关人员欺诈骗保典型案例，这是自2025年9月以 来国家医保局发布的第三批相关典型案例。 本次公开的典型案例包括：辽宁省抚顺市博爱医院串换诊疗服务项目欺诈骗保案例、贵州省六盘水市水 旷医院(现水矿医院)虚构诊疗服务项目欺诈骗保案例、浙江省嘉兴平湖市聚隆大药房协助冒名购药骗取 医保基金案例等。这些案例涉及虚假就医、串换药品等骗取、套取医保资金行为，被查处的人员既有医 疗机构医务人员，也有零售药房的执业药师。 (经济观察网杜远/文) 2025年9月，国家医保局公开发布第一批"各地医保部门落实定点医药机构相关人员医保支付资格管理制 度典型案例"，意在震慑违规违法套取、骗取医保资金的人员，并指导各地医保部门做好基金监管执法 和日常管理。 值得注意的是，所公布案例中，甚至有"村医"有组织地非法收集大量社保卡或医保码，长时间持续性地 虚构医药服务，骗取医保资金。 据通报，2025年4月，江西省九江市永修县医保局通过数据排查发现，2024年1月至2025年3月，该县虬 津镇张公渡村卫生室通过医保结算5565人次，医疗总费用25.95万元，医保报销22.81万元，其中特困人 ...

Investment Rating - The report suggests a positive investment outlook for the innovative drug sector and anticipates a reversal of challenges in the left-side sectors, identifying them as the biggest investment opportunities in the pharmaceutical sector for 2025 [4]. Core Insights - The launch of the Ant Group's AI health application "Antifufu" has significantly increased attention on the medical AI theme, addressing previous issues in internet healthcare such as low user engagement and limited access to quality medical resources [1][12]. - Takeda's TYK2 inhibitor Zasocitinib has successfully met all primary and secondary endpoints in its Phase III clinical trials for moderate to severe plaque psoriasis, with over 50% of patients achieving PASI 90 and approximately 30% achieving PASI 100 by week 16 [2][44]. - The report highlights the successful results of Eli Lilly's orforglipron in maintaining weight loss over 52 weeks, indicating its potential to extend the usage cycle of GLP-1 medications [2][46]. Summary by Sections AI Medical Applications - The Antifufu app has upgraded its features to include health companionship, health Q&A, and health services, effectively increasing user engagement and linking patients with medications and services [1][12]. - The platform connects with 5,000 hospitals and 300,000 real doctors, democratizing access to quality medical resources [1][12]. Pharmaceutical Sector - Takeda's Zasocitinib has shown promising results in clinical trials, with plans to submit a new drug application to the FDA and other regulatory bodies by the 2026 fiscal year [2][44]. - The report emphasizes the potential of innovative drugs, particularly dual/multi-antibody drugs and those addressing unmet clinical needs in chronic diseases, as key investment opportunities [4]. Biologics - Eli Lilly's orforglipron has demonstrated superior weight maintenance compared to placebo, suggesting a promising future for GLP-1 drugs [2][46][48]. Medical Devices - The domestic continuous glucose monitoring (CGM) market is expected to expand, driven by rapid product iterations and improvements in quality and patient acceptance [3]. Retail Pharmacy - The report notes that leading companies in the pharmacy sector are likely to increase market share through mergers and acquisitions during the industry consolidation phase [3]. Medical Services and Consumer Healthcare - The AI medical market is being validated as a scalable business model, with ongoing developments in AI healthcare applications [3][4]. Key Investment Targets - The report identifies several key companies for investment consideration, including Innovent Biologics, Kintor Pharmaceutical, and others in the pharmaceutical and healthcare sectors [5].

Core Viewpoint - The establishment of a one-stop comprehensive service center at Zhoukou Central Hospital significantly enhances patient experience by streamlining processes, allowing patients to complete 109 services with just an ID card, thus embodying the principle of "one visit, one completion" [1][3] Group 1: Healthcare Reform Achievements - Zhoukou's healthcare reform has effectively addressed issues such as resource imbalance and cumbersome medical processes by integrating multiple service sectors through information technology [3][4] - The city has invested 160 million yuan to build a unified health information platform, facilitating real-time data sharing across departments and institutions, with over 530 million medical, insurance, and pharmaceutical data records collected [3][4] - In Dancheng County, the mutual recognition of inspection results has saved patients 3.79 million yuan, and the completion rate for outpatient medical examinations within 24 hours has improved from 62.86% to 95.75% [3][4] Group 2: Community Healthcare Improvements - The establishment of tightly-knit medical communities and urban medical groups has enhanced the integrated healthcare service model, improving access to medical services for rural populations [4][6] - Local health services have been enhanced with remote consultation capabilities, allowing village health clinics to provide timely care for chronic and minor illnesses, significantly reducing the need for patients to travel to county hospitals [6][7] - The insurance coverage rate in Dancheng County has reached 98.2%, and the income of village doctors has generally increased, with 100% of village clinics now able to offer traditional Chinese medicine services [6][7] Group 3: Future Goals and Strategies - Zhoukou's health authorities aim to further improve healthcare capacity, optimize systems, strengthen grassroots services, and promote health through a collaborative approach to policy reform [7] - The focus will be on enhancing the integration of quality resources, making healthcare more accessible and affordable for the public, while leveraging data intelligence to support decision-making and precise services [7]